Kawai K, Hayakawa H, Yoshida K, Shimizu M, Noto Y
Diabete Metab. 1977 Mar;3(1):7-10.
Fifty grams of glucose were administered orally to twelve cirrhotics, twelve uremics and ten normal controls and the plasma insulin and C-peptide responses were measured and expressed as molar concentration. Glucose intolerance, hyperinsulinemia and elevated C-peptide levels were found in cirrhotics after glucose loading and in uremics during the later part of the glucose response. The molar ratio of C-peptide to insulin was lower in cirrhotics and higher in uremics than in controls. It is suggested that insulin is mainly degraded by the liver and C-peptide by the kidneys, and that C-peptide is not affected by the liver damage but is present in raised concentration in subjects with injured kidneys. Elevated C-peptide level in cirrhotics is consistent with hyperfunction of pancreatic B-cells.
给12名肝硬化患者、12名尿毒症患者和10名正常对照者口服50克葡萄糖,测量血浆胰岛素和C肽反应,并以摩尔浓度表示。在葡萄糖负荷后,肝硬化患者出现葡萄糖耐量异常、高胰岛素血症和C肽水平升高,在尿毒症患者中,在葡萄糖反应后期也出现这些情况。肝硬化患者的C肽与胰岛素的摩尔比低于对照组,而尿毒症患者则高于对照组。提示胰岛素主要由肝脏降解,C肽主要由肾脏降解,C肽不受肝脏损害影响,但在肾脏受损的患者中浓度升高。肝硬化患者C肽水平升高与胰腺β细胞功能亢进一致。